Pathway enrichment analysis showed that Wnt10A and Wnt11 may participate in the biological process of AML by interacting with genes in ‘cell morphogenesis involved in differentiation’, ‘blood vessel development’, ‘haemostasis’ and ‘haematopoietic cell lineage’ signalling pathways. Here, WNT10A is linked to acute myeloid leukemia.